The frequency of NSE-positivity in ALL was similar to that in small cell lung cancer (about 70%) and higher than that previously reported in Hodgkin's lymphoma (6.5%) and Non-Hodgkin's lymphoma (17.2%) [14, 24]. The gene discussed is ENO2; the disease is Hodgkins lymphoma.